Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.

Sexually transmitted diseases - 1 Feb 2018

Allan-Blitz Lao-Tzu, Hemarajata Peera, Humphries Romney M, Wynn Adriane, Segura Eddy R, Klausner Jeffrey D

Abstract excerpt

BACKGROUND: Novel approaches to combating drug-resistant Neisseria gonorrhoeae infections are urgently needed. Targeted therapy with ciprofloxacin has been made possible by a rapid assay for genotyping the gyrase A (gyrA) gene; a nonmutated gene reliably predicts susceptibility to ciprofloxacin. METHODS: We determined the costs of running the gyrA assay, 500 mg of ciprofloxacin, 250 mg of ceftriaxone injection,...

Topics

Join the communities discussing this publication.

Azithromycin
California
Ceftriaxone
Ciprofloxacin
Costs and Cost Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Neisseria gonorrhoeae

Source

Open in PubMed Open full text

Identifiers

PMID: 29329176
DOI: 10.1097/OLQ.0000000000000698
PMCID: PMC6879096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.PMID 29329176Read ↗

Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.Semantic proximity Read ↗

Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA.Semantic proximity Read ↗

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.Semantic proximity Read ↗

Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.Semantic proximity Read ↗

Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.Semantic proximity Read ↗

Molecular Diagnostics for Gonorrhoea: Implications for Antimicrobial Resistance and the Threat of Untreatable GonorrhoeaSemantic proximity Read ↗

Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.Semantic proximity Read ↗

Development of Cas13a-based assays for Neisseria gonorrhoeae detection and gyrase A determinationSemantic proximity Read ↗

Targeted surveillance strategies for efficient detection of novel antibiotic resistance variantsSemantic proximity Read ↗

Genotypic determinants of fluoroquinolone and macrolide resistance in Neisseria gonorrhoeaeSemantic proximity Read ↗

Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.Semantic proximity Read ↗

Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.